Pranlukast

Drug Profile

Pranlukast

Alternative Names: Azlaire; Dolukast hydrate; ONO 1078; ONO RS 411; Onon; Onon Capsule; Onon Dry Syrup; RS 411; SB 205312; Ultair

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ono Pharmaceutical
  • Developer Merck & Co; Ono Pharmaceutical
  • Class Antiallergics; Antiasthmatics; Chromones; Small molecules
  • Mechanism of Action Leukotriene C4 receptor antagonists; Leukotriene D4 receptor antagonists; Leukotriene E4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Allergic rhinitis; Asthma
  • Discontinued Chronic obstructive pulmonary disease; Inflammatory bowel diseases; Sinusitis

Most Recent Events

  • 22 Dec 2011 Registered as dry syrup formulation for Allergic rhinitis (in children) in Japan (PO)
  • 30 Apr 2011 Preregistration as dry syrup formulation for Allergic rhinitis (in children) in Japan (PO)
  • 17 Mar 2009 Pharmacokinetics data from a phase I trial in patients with Asthma presented at the 65th Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI-2009)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top